Patients with SLE vs individuals without autoimmune disease demonstrated higher rates of peripartum complications.
More than 50% of patients with systemic lupus erythematosus (SLE) develop lupus nephritis (LN) during the disease, which may ...
Objective Combination therapy with rituximab and belimumab is a novel treatment strategy for severe SLE and lupus nephritis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results